NCT04264897View on ClinicalTrials.gov

Antecedent Metabolic Health and Metformin Aging Study

PHASE3CompletedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

July 29, 2020

Primary Completion Date

March 12, 2025

Study Completion Date

March 12, 2025

Conditions
AgingInsulin SensitivityChronic DiseaseMitochondriaInsulin Resistance
Interventions
DRUG

Metformin

"Metformin (Hunter Pharmacy) following a ramp up dosing protocol with a targeted dose of 1500 mg/day for 12 weeks."

DRUG

Placebo oral tablet

Silicified microcrystalline cellulose, Micosolle®, K30 povidone, sodium starch glycolate, and magnesium stearate

Trial Locations (2)

53705

University of Wisconsin-Madison, Madison

73104

University of Oklahoma Health Sciences Center, Oklahoma Shared Clinical and Translational Resources, Oklahoma City

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

collaborator

University of Oklahoma

OTHER

collaborator

University of Wisconsin, Madison

OTHER

lead

Oklahoma Medical Research Foundation

OTHER

NCT04264897 - Antecedent Metabolic Health and Metformin Aging Study | Biotech Hunter | Biotech Hunter